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http://dxObjective: There is cross-center variability with regard to timing repair of non–ductal-dependent tetralogy of
Fallot (TOF). We hypothesized that earlier repair in the neonatal period is associated with increased mortality
and morbidity.
Methods: This was a retrospective analysis of the Pediatric Health Information System of tetralogy of Fallot
patients undergoing complete repair from 2004 through 2010 between the ages of 1 day to younger than 19 years.
Patients with pulmonary valve atresia, those who received prostaglandin during hospital admission, and those
who underwent prior shunt palliation were excluded.
Results: A total of 4698 patients met our inclusion criteria, of whom 202 were younger than 30 days old (group
A), 861 were 31 to 90 days old (group B), 1796 were 91 to 180 days old (group C), and 1839 were older than 180
days (group D). In-hospital mortality, intensive care unit length of stay, and total hospital length of stay were
significantly higher in group A. Patients in group A had a significantly increased postoperative requirement
for mechanical ventilation, intravenous blood pressure support, medical diuresis, extracorporeal membrane
oxygenation, gastrostomy tube insertion, heart catheterization, and surgical revision. Significant institutional
variability was noted for timing of TOF complete repair, with one third of the centers performing 75% of the
repairs at younger than 30 days old. The institutional approach to timing TOF complete repair showed no
relation to surgical volume.
Conclusions: Across all centers analyzed, primary neonatal elective TOF repair (<30 days of age) is associated
with significantly higher postoperative in-hospital morbidity and mortality, although a few centers have shown
an ability to use this strategy with excellent survivability. (J Thorac Cardiovasc Surg 2014;147:1299-305)C
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DTetralogy of Fallot (TOF) represents 5% to 7% of all
congenital cardiac lesions1 and is the most common form
of cyanotic congenital heart disease, with a prevalence of
approximately 3.9 per 10,000 live births.2 As the first
intracardiac lesion to be addressed surgically, with the
creation of a systemic to pulmonary artery shunt by Alfred
Blalock3 in 1945, the surgical strategy has evolved consid-
erably over the years, and mirrors the evolution of the field
of cardiothoracic surgery as a whole. In the 1950s and 1960s
high mortality precluded complete neonatal primary repair
and the accepted approach was a 2-stage repair, with initial
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The Journal of Thoracic and Carcomplete repair at a later age. With the innovation of
hypothermic circulatory arrest in the 1970s, the approach
began to shift from initial shunt palliation toward primary
repair.4,5
Over subsequent decades, advancements in surgical
techniques and postoperative intensive care unit (ICU)
care allowed for primary complete repair on younger and
smaller infants.6 The trend in management has been shifting
over time toward complete repair performed at an earlier
age,7 and some centers have adopted a strategy of elective
primary repair for asymptomatic patients in the neonatal
period.8,9 The physiologic rationale underlying early
primary repair strategies include the prevention of
cyanotic end organ damage, removing the stimulus for
right ventricular hypertrophy and fibrosis, promoting
pulmonary artery growth, and improved vascular and
alveolar lung development.10-12
With some centers progressing toward repair for asymp-
tomatic TOF in the early neonatal period, there has been
concern for increased potential postoperative morbidity
associated with subjecting a fragile newborn to an elective
cardiac surgery. Considerable controversy exists as to the
optimal timing of repair,13 and a recent multicenter analysis
has shown that significant cross-center variability exists
concerning timing strategy.14diovascular Surgery c Volume 147, Number 4 1299
Abbreviations and Acronyms
ECMO ¼ extracorporeal membrane oxygenation
ED ¼ emergency department
ICD-9 ¼ International Classification of Diseases,
9th revision
ICU ¼ intensive care unit
LOS ¼ length of stay
PGE1 ¼ prostaglandin E1
PHIS ¼ Pediatric Health Information System
TOF ¼ tetralogy of Fallot
Congenital Heart Disease Steiner et al
C
H
DTo our knowledge, there have been no multi-institutional
studies relating immediate postoperative hospital-based
outcomes to timing of elective repair of TOF. We hypothe-
sized that earlier repair of asymptomatic infants in the
neonatal period was associated with increased mortality
and morbidity. A large multicenter database of pediatric
hospital admissions was queried to determine the preva-
lence of alternative strategies with regard to timing of
elective complete repair. The objective of the study was to
identify an association of postoperative morbidity and
mortality to age of complete repair.METHODS
The University of Arkansas for Medical Sciences Institutional Review
Board for the Protection of Human Subjects reviewed the study protocol
and determined that querying de-identified patient data does not fall un-
der the jurisdiction of the Institutional Review Board review process.
Data Source
Patient demographic data and data relating to postoperative outcomes
were abstracted from the Pediatric Health Information System (PHIS),
an administrative database that contains inpatient data from 43 free-
standing, tertiary care children’s hospitals in North America.15 Institutions
are affiliated with the Child Health Corporation of America (Shawnee
Mission, Kan), a business alliance of children’s hospitals, and account
for 20% of all tertiary care children’s hospitals. Institutions are labeled
within the database but cannot be identified in public reporting. For the
purposes of external benchmarking, participating hospitals provide
discharge data including demographic information as well as diagnoses
and procedures coded with International Classification of Diseases, 9th
Revision (ICD-9) codes.16 Billing data also are available detailing medica-
tions, imaging studies, laboratory tests, and supplies charged to each
patient, and are coded under the Clinical Transaction Classification
(CTC) System (Truven Health Analytics, Ann Arbor, Mich).17 Data quality
and reliability are ensured through a joint effort between the Child Health
Corporation of America and participating hospitals. The data warehouse
function for the PHIS database is managed by Thomson Healthcare
(Durham, NC). Individual patient medical record numbers, billing
numbers, and zip codes are encrypted. Data are de-identified at the time
of submission and are subjected to a number of reliability and validity
checks before being processed into data quality reports. Data are accepted
into the database once classified errors occur less frequently than a criterion
threshold, and the database is updated quarterly by the Child Health Cor-
poration of America. If a hospital’s quarterly data are unacceptable accord-
ing to these limits, all of their quarterly data are rejected; however, these
data can be resubmitted and re-evaluated before inclusion in the database.181300 The Journal of Thoracic and Cardiovascular SurPHIS data updates through the fourth quarter of 2011 are reflected in our
data set.
Identification of the Study Population
The study group was defined as all patients between the ages of 1 day to
younger than 19 years who were discharged from a PHIS-participating
hospital between January 1, 2004, andDecember 31, 2010, with a diagnosis
of TOF (ICD-9 code, 745.2) who underwent surgical complete repair
(ICD-9 code, 35.81) during their admission.
Exclusion Criteria
Patients with a co-existing diagnosis of pulmonary valve atresia (ICD-9
code, 746.01), patients who were administered prostaglandin E1 (PGE1)
(CTC code, 191315) at any time during the admission, and patients with
a history of having undergone a prior systemic to pulmonary artery shunt
surgery (ICD-9 code, 39.0) were excluded from the analysis. Patients
with an Emergency Department (ED) charge during the admission also
were excluded. The rationale for exclusion of these groups was an effort
to eliminate symptomatic patients requiring urgent surgical attention,
thus analyzing only the electively repaired patients around which the con-
troversy of optimal timing of complete repair is centered. Because early
and/or emergent surgical intervention generally is required in cases of pul-
monary atresia and ductal-dependent pulmonary circulation, these groups
were excluded from the analysis. Likewise, if a patient presented to the
ED and subsequently was admitted and underwent a TOF repair during
the admission, it is reasonable to assume that surgery was performed on
a nonelective basis. A total of 422 patients were excluded based on
receiving prostaglandin, 274 patients were excluded because an ED charge
was associated with the admission, and 562 patients were excluded on the
basis of having undergone a prior shunt palliation. Patients who were
admitted and underwent surgical repair in 2003 but were discharged in
2004 also were excluded from the analysis. Figure 1 shows the inclusion
and exclusion criteria underlying the make-up of our cohort.
Variables Queried
Patient abstract data queried included the following: age, sex, presence
of a chromosomal abnormality, dates of admission and discharge, history of
prior shunt palliation, total hospital length of stay (LOS), ICU LOS, post-
operative days requiring mechanical ventilation, whether an ED encounter
was associated with the admission, and hospital code performing the
surgery.
To identify patients with a history of shunt palliation before complete
surgical repair, all cases of hospital admissions with a diagnosis of TOF
excluding pulmonary atresia within the date range were screened for
systemic to pulmonary artery shunt (ICD-9 code, 39.0). Identification
numbers for these patients were noted and cross-checked against the
patients in the cohort meeting all the inclusion criteria and who underwent
a complete repair. If the shunt surgery occurred before the complete
surgical repair it was counted as a prior palliation. This enabled us to
determine which patients had a history of prior shunt palliation occurring
on a previous admission to complete repair, so as to exclude these patients
from the analysis.
Various interventions associated with postsurgical morbidity were
analyzed for their relative frequency of occurrence. These interventions
included extracorporeal membrane oxygenation (ECMO) (ICD-9 code,
39.65), ventricular assist device (ICD-9 code, 37.6x), pacemaker implanta-
tion (ICD-9 code, 37.81-83), hemodialysis (ICD-9 code, 39.95), peritoneal
dialysis (ICD-9 code, 54.98), pericardiocentesis (ICD-9 code, 37.0),
pericardiotomy (ICD-9 code, 37.12), thoracentesis (ICD-9 code, 34.91),
chest tube insertion (ICD-9 code, 34.04), pluerodesis (ICD-9 code,
34.92), gastrostomy tube insertion (ICD-9 code, 43.0, 43.11-43.19),
cardiac catheterization (ICD-9 code, 37.21-37.23), and blood product
transfusion (ICD-9 code, 99.00-99.06). Requirement for surgical revisiongery c April 2014
FIGURE 1. Study population. TOF, Tetralogy of Fallot; ED, emergency department.
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Dwas queried as either revision of surgical procedure on the heart (ICD-9
code, 35.95) or subsequent instances of surgical complete repair of TOF
(ICD-9 code, 35.81). Only interventions occurring during the same hospital
admission as the complete repair of TOF were included.
Abstracted pharmacy data included names of medications administered,
route of administration, and number of postoperative days required. In the
case of prostaglandin, any administration during the admission was consid-
ered. Inotropes/pressors administered included epinephrine (CTC code,
131321), milrinone (CTC code, 131111), norepinephrine (CTC code,
131351), dopamine (CTC code, 131311), dobutamine (CTC code,
131305), and fenoldopam (CTC code, 134111). Diuretics included furose-
mide (CTC code, 191135), bumetanide (CTC code, 191131), chlorothia-
zide (CTC code, 191111), and hydrochlorothiazide (CTC code, 191113).
The total hospital charges associated with each surgical admission were
abstracted from thedatabase.Chargeswere converted to 2010dollarsbymulti-
plying the 2010 consumer price index adjustment factors and dividing by the
consumer price index factor for the year in which the charges were incurred
(discharge year). The consumer price index adjustment factors were down-
loaded online (ftp://ftp.bls.gov/pub/special.requests/cpi/cpiai.txt).
Definitions
For the purposes of this study, a neonate was defined as younger than
30 days old. Elective complete TOF repair was defined as complete TOF
repair performed on a patient who had not been administered PGE1
during the hospital admission, had not undergone a prior shunt
palliation, and had not had an ED encounter associated with the admis-
sion. Hospital mortality was defined as death before discharge. Days forThe Journal of Thoracic and CarLOS variables were defined as any portion of a calendar day before
discharge. Postoperative days requiring pressors/inotropes (epinephrine,
milrinone, norepinephrine, dopamine, dobutamine, or fenoldopam) was
defined as a summation of the total number of postoperative calendar
days for which each medication was administered. Postoperative days
requiring medical diuresis was defined as a summation of the total
number of postoperative calendar days in which any of the follow-
ing were administered: furosemide, bumetanide, chlorothiazide, or
hydrochlorothiazide.
Statistical Analysis
All the data were analyzed using R v2.15.0 (R Development Core Team,
Vienna, Austria). Descriptive statistics were expressed as medians and
interquartile ranges for continuous variables, and percentages and
frequencies for categoric variables.Wecompared thedemographic and clinical
data among the 4 age groups using the Kruskal-Wallis 1-way analysis of vari-
ance for continuous variables, and the chi-square test for categoric variables.
Kaplan-Meier curves were plotted for hospital LOS, ICU LOS, and the dura-
tion of mechanical ventilation for each age group. Log-rank tests were
performed to evaluatewhether therewas a significant difference in the survival
distribution among the 4 age groups with respect to hospital LOS, ICU LOS,
and duration of mechanical ventilation. Deaths before discharge were consid-
ered to be censored when we assessed the difference in in-hospital morbidity
among age groups. The percentages of children having complete repair in
different age groups were calculated for each center, and the chi-square test
was performed to evaluate the center variability in the age distribution for
complete repair. P values less than .05 indicated statistical significance.diovascular Surgery c Volume 147, Number 4 1301
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DRESULTS
Cohort Description
The summaries and testing results are shown in Table 1. Of
the 4698 subjects who met our inclusion criteria, the median
age at complete repair was 153 days (interquartile range, 96-
239 days) and the mean age at complete repair was 332 days
(standard deviation, 760 days). A total of 42.4% of the cohort
was female and 6.3% had a co-existing chromosomal
abnormality.
To determine the distribution of morbidity and mortality,
the cohort was stratified by age at complete repair into the
following groups. Group A: 0 to 30 days (n ¼ 202;
4.3%); group B: 31 to 90 days (n ¼ 861; 18.3%); group
C: 91 to 180 days (n ¼ 1796; 38.2%); and group D: 181
days to 18 years (n ¼ 1839; 39.1%).TABLE 1. Summaries of demographic and clinical data by age at complet
N
Group A:
0-30 days
(N ¼ 202)
G
31
(N
Demographic data
Age at surgery (d) 4698 16 (9-23) 67
Female 4698 40% (81) 41%
Year surgery 4698 2008 (2006-2010) 2008
Chromosomal abnormality 4698 3% (7) 5%
Outcome data
Death before discharge 4698 6.4% (13) 1.9%
Hospital LOS (d) 4698 18 (12-32) 8
ICU LOS (d) 4698 9 (5-17) 5
Length of mechanical
ventilation (d)
4698 3 (0-7) 1
Time on pressers/inotropes (d) 4698 4 (2-6) 3
Time on diuretics (d) 4698 11 (7-19) 7
Dysrhythmias 4698 9% (19) 12%
Interventions
Transfusion blood 4698 42% (84) 47%
Chest tube insertion 4698 11% (22) 8%
Heart Catheterization 4698 7% (14) 4%
ECMO 4698 4% (8) 1%
Gastrostomy 4698 7% (14) 3%
Pacemaker 4698 2% (5) 1%
Peritoneal dialysis 4698 1% (2) 1%
Surgical revision 4698 4% (9) 1%
Thoracentesis 4698 2% (4) 1%
Pericardiotomy 4698 0% (0) 0%
Pericardiocentesis 4698 0% (1) 0%
Hemodialysis 4698 0% (1) 0%
VAD 4698 0% (1) 0%
Pluerodesis 4698 0% (1) 0%
Hospital charges
Adjusted billed charges,
2010 dollarsy
4698 244,192
(141,370-395,570)
136,43
(99,5
Raw billed charges 4698 239,747
(137,081-379,070)
133,14
(95,1
Data are expressed as median (interquartile range), or percentage (number). VAD, Ventricu
membrane oxygenation. *P values were obtained using the Kruskal-Wallis 1-way analysis
yAdjusted billed charges were converted to 2010 dollars using annual average adjustment
1302 The Journal of Thoracic and Cardiovascular SurPostsurgical In-Hospital Mortality
Increased hospital mortality was found to be associated
significantly with younger age at repair. Across all age
ranges there were 63 deaths before discharge (1.3%). Death
before discharge occurred in 6.4% of the neonatal group
(group A), and in 1.9%, 0.7%, and 1.1% of groups B, C,
and D, respectively (P<.001).
Postsurgical In-Hospital Morbidity
Duration of total hospital LOS, ICU LOS, and postop-
erative mechanical ventilation were found to have an
inverse relationship with age at repair. The median group
A ICU LOS was 9 days, which was significantly higher
compared with group B (median, 5 days), group C
(median, 4 days), and group D (median, 3 days). Similarly,e repair
roup B:
-90 days
¼ 861)
Group C:
91-180 days
(N ¼ 1796)
Group D: 181 days
to 18 years
(N ¼ 1839) P*
(51-80) 133 (111-155) 277 (214-472)
(350) 40% (721) 46% (841) .003
(2006-2010) 2008 (2006-2009) 2007 (2005-2009) <.001
(45) 7% (124) 7% (120) .127
(16) 0.7% (14) 1.1% (20) <.001
(6-15) 7 (5-10) 7 (5-10) <.001
(3-8) 4 (2-6) 3 (2-6) <.001
(0-3) 0 (0-2) 0 (0-2) <.001
(2-4) 2 (1-4) 2 (1-4) <.001
(5-11) 6 (5-9) 6 (5-9) <.001
(103) 8% (145) 6% (111) <.001
(408) 45% (809) 45% (828) .433
(67) 7% (120) 8% (140) .156
(31) 2% (40) 3% (58) .002
(12) 1% (18) 1% (26) .008
(23) 1% (14) 0% (8) <.001
(8) 2% (27) 1% (14) .048
(8) 1% (15) 1% (17) .989
(7) 1% (13) 0% (7) <.001
(6) 1% (14) 1% (18) .323
(3) 0% (4) 1% (10) .335
(2) 0% (5) 0% (6) .927
(2) 0% (1) 0% (6) .264
(3) 0% (1) 0% (0) .019
(1) 0% (0) 0% (0) .006
6
51-232,943)
112,122
(84,379-156,560)
106,230
(79,997-158,666)
<.0001
6
37-221,126)
107,424
(79,996-152,857)
101,510
(75,444-150,809)
<.001
lar assist device; LOS, length of stay; ICU, intensive care unit; ECMO, extracorporeal
of variance for continuous variables, and the chi-square test for categoric variables.
factors (available from: ftp://ftp.bls.gov/pub/special.requests/cpi/cpiai.txt).
gery c April 2014
Steiner et al Congenital Heart Diseasetotal hospital LOS was significantly higher in group A
(median, 18 days), compared with group B (median, 8
days), and groups C and D (median, 7 days). Group A pa-
tients had a greater requirement for mechanical ventila-
tion, with a median of 3 postoperative days intubated in
comparison with 1 day for group B, and 0 days for groups
C and D. Figure 2 shows Kaplan-Meier curves for hospital
LOS, ICU LOS, and the duration of mechanical ventila-
tion by age groups.
The following interventions were associated with
increased postoperative morbidity and were found to have
a significant correlation with younger age at complete
repair: need for surgical revision, ECMO, gastrostomy
tube insertion, heart catheterization, and pacemaker
implantation. Requirement for surgical revision before
discharge occurred with more than 5-fold increased
frequency in group A patients.
Time to be weaned off all pressors/inotropes was signif-
icantly longer for group A (median, 4 days) in comparison
with group B (median, 3 days), and groups C and D (me-
dian, 2 days). The duration of the postoperative diuretic
requirement was significantly longer for group A (median,
11 days) in comparison with group B (median, 7 days),
and groups C and D (median, 6 days).C
H
DHospital Charges
Themedian total billed hospital charges, adjusted to 2010
dollars, were found to be significantly higher in group A
($244,192) in comparison with group B ($136,436), group
C ($112,122), and group D ($106,230).FIGURE 2. A, Kaplan-Meier curves for total hospital LOS by age group.
B, Kaplan-Meier curve for ICU LOS by age group. C, Kaplan-Meier curve
for duration ofmechanical ventilationby age group. ICU, Intensive care unit.Center Variability
Figure 3 shows a bar plot of the percentage of surgical
distribution of group A repairs by center, with marks
overlaid representing total surgical volume that met
inclusion criteria. It is notable that center preference with
regards to propensity to perform group A repairs showed
no linear correlation to volume of repairs performed;
some high-volume centers showed group A representing a
relatively small proportion of their distribution, whereas
some low-volume centers showed group A representing a
relatively large proportion of their distribution.
Within the entire cohort of 4698 subjects, group A repairs
were performed with a mean frequency of 4%, represented
as a horizontal line in Figure 3. The 13 centers with group A
surgical distribution greater than 4% cumulatively per-
formed 153 of the total group A repairs, meaning that one
third of the centers (13 of 39) performed more than 75%
of the total group A repairs (153 of 202). Four institutions
in the cohort were particularly inclined to perform group
A repairs, performing them at a rate greater than 3 times
that seen in the cohort as a whole, and with greater than
10% of their surgical distribution categorized as group A.The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 4 1303
FIGURE 3. Percentage of surgical distribution of neonatal (group A)
repairs for each hospital (vertical bars correspond to the left-side of the
y-axis). Each hospital’s total number of surgeries performed across all
age groups meeting inclusion criteria also is shown (diamonds correspond
to the right-side of the y-axis). A horizontal line is drawn at 4%, the mean
percentage distribution of group A surgeries performed across the entire
cohort of 4698 subjects at all 39 hospitals.
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DMortality by Center
A subanalysis of the distribution of mortality stratified by
age at repair within each center was performed. It was
notable that among the 4 centers noted earlier to show a
particular propensity for performing neonatal repairs, 3
experienced no mortality within group A.
Among the 13 centers performing group A repairs with
relative frequency (>4% of their caseload), there were 4
group A deaths of 153 group A patients, representing a
2.6% mortality rate for group A. Although considerably
better than the overall group A mortality rate (6.4%), it is
still twice the mortality rate seen across all age groups
(1.3%).
Among the remaining hospitals with a relative disinclina-
tion to perform group A repairs (<4% of their caseload),
there were 9 group A deaths of 49 group A patients. This
represents a group A mortality rate of 18.4%, which is
nearly triple the overall group A mortality of 6.4%.DISCUSSION
Our data confirm our hypothesis, suggesting that, across
all centers, complete primary repair of acyanotic TOF in
neonates (<30 days old) is associated with increased
mortality and morbidity. We found a significantly higher
overall in-hospital postoperative mortality rate (6.4%) for
elective neonatal complete repairs. In addition, total billed
hospital charges, the total hospital LOS, ICU LOS, time
until extubation, postoperative requirement for revision,
medications, and secondary procedures all were increased
significantly for elective neonatal complete repairs. There
is no consensus regarding the optimal timing of complete
repair of acyanotic TOF, and to our knowledge this is the
first large-scale multi-institutional analysis of postsurgical
morbidity stratified by age at complete repair.1304 The Journal of Thoracic and Cardiovascular SurWith advancement in intraoperative technology and
postoperative ICU care there is an increasing trend to move
toward primary complete surgical repair,19 reserving initial
palliation only for extreme cases with limiting anatomic
features such as anomalous coronary arteries or pulmonary
artery discontinuity.12 Because forgoing the step of initial
shunt palliation and performing early primary neonatal
repair has become an accepted strategy for these cyanotic in-
fants7 with pulmonary atresia or severe right ventricular
outflow tract obstruction, some centers have extended this
strategy to include asymptomatic infants. There was a
single-center experience to show that the strategy can be
performed safely,8,9 but the escalated need for ICU care
has led other centers to advocate delaying repair in
asymptomatic neonates until after 3 months of age.20 Thus,
optimal timing for complete primary repair of asymptomatic
TOF has remained controversial. These data would suggest
that, when possible, delaying complete repair of asymptom-
atic infants until a later age could have an increased survival
benefit, as well as decreased postoperative morbidity.
Relative differences in functionalmaturity across all organ
systems might provide a mechanistic understanding of our
findings. In particular, alveolarization in the lungs and
nephron maturation in the kidneys continue postnatally. Al-
lowing time for further maturation of these organ systems
may allow older infants to better handle the stress of surgery
and enhance postoperative recovery.Recovery frompediatric
cardiac surgery can be tenuous in the best of circumstances,
and our data suggest that the fragility of the newborn period
complicates and prolongs the postoperative course.
By excluding infants with pulmonary atresia, those who
were administered prostaglandin, those who underwent
prior shunt palliation, and those who presented to an
emergency room and went on to require surgery, we have
attempted to eliminate symptomatic emergent repairs and
analyze cases of elective primary complete repair of asymp-
tomatic infants. The extreme variation of age distribution
found between centers, with a substantial number of centers
performing few or no neonatal repairs whereas others
performed neonatal repairs as a significant percentage of
their caseload, suggests that the age range variation found
in our cohort was a function of differences of strategic
preference with regards to timing, and not dictated by
symptomatology or anatomy. The subgroup analysis
showed that centers favoring the strategy of early repair
did in fact achieve lower mortality than what was found
for early repairs overall, with the bulk of the deaths
occurring at institutions performing early repairs as a
smaller percentage of their surgical distribution. It was
notable that 3 of the 4 centers showing a particular propen-
sity to perform neonatal repairs did not experience any
group A mortality whatsoever, indicating that it is possible
to achieve excellent survivability when a center has
committed to this strategy.8 The by-center analysis forgery c April 2014
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Dmorbidity, however, still mirrored that seen across the entire
cohort, with total hospital LOS, ICU LOS, time on mechan-
ical ventilation, medication requirement, and postoperative
procedural complication rates all increased with earlier
repairs, even at centers achieving low mortality after
neonatal repair.
Study Limitations
The study data provide limited specific details of cardiac
anatomy (degree of subpulmonary stenosis, pulmonary
valve annulus size, and coronary and pulmonary artery
morphology), and limited specific details of surgical
variables (transannular patch placement vs valve-sparing
techniques, surgical approach via a right ventriculotomy
vs via the right atrium or pulmonary artery,18 length of
infundibulectomy,14 duration of cardiopulmonary bypass
time, and aortic cross-clamp time). Specific details of the
clinical course (threshold for starting PGE, extended
follow-up evaluation throughout subsequent hospitaliza-
tions and outpatient visits) also were limited. Patients who
might have undergone shunt placement before the date range
or at a different hospital from the one where they underwent
complete repair were not counted as having undergone an
initial first stage; thus, some patients with a history of a prior
shunt may not have been identified for exclusion. Also, it
should be noted that a recent study raised concern for differ-
ences in case ascertainment when comparing the number of
cases of pediatric cardiac surgery abstracted from the PHIS
database with the number of cases abstracted from the
clinical Society of Thoracic Surgeon’s database.21
Finally, the study was subject to the limitations of any
observational investigation, including selection bias and
the potential impact of confounders. Despite the limitations
inherent in an administrative database such as the PHIS, we
believe that there is a strong ability to address immediate
postoperative outcome measures correlated to timing
strategy, and that the limitations of the database are
outweighed by the magnitude of the sample size.
CONCLUSIONS
Primary neonatal elective TOF repair is associated with
significantly higher postoperative in-hospital mortality,
although selected centers have shown an ability to use this
strategy with excellent survivability. It is associated with
increased morbidity (ICU LOS, total hospital LOS, duration
of mechanical ventilation, requirement for intravenous
blood pressors/inotropes, duration of medical dieresis,
postoperative requirement for ECMO, surgical revision,
cardiac catheterization, and gastrostomy tube placement)
and increased resource use as reflected by the total cost of
hospital admission. Future directions of this research might
include merging our data with large surgical databases to
seek differences associated with variable postoperative out-
comes within each age group based on detailed preoperativeThe Journal of Thoracic and Carand peri-operative surgical risk factors. A prospective
study following up patients with early versus late repair of
asymptomatic TOF to determine mid- and late-term
outcomes would provide additional information to aid
cardiologists and surgeons in deciding on the optimal
time for repair of this challenging group of infants.
References
1. Talner CN. Report of the New England Regional Infant Cardiac Program.
Pediatrics. 1980;65(Suppl):375-461.
2. Improved national prevalence estimates for 18 selected major birth defects –
United States 1999–2001. MMWR Morb Mortal Wkly Rep. 2006;54:1301-5.
3. Blalock A. Physiopathology and surgical treatment of congenital cardiovascular
defects. Harvey Lect. 1955;41:90-116.
4. Barratt-Boyes BG, Neutze JM. Primary repair of tetralogy of Fallot in infancy
using profound hypothermia with circulatory arrest and limited cardiopulmonary
bypass: a comparison with conventional two stage management. Ann Surg. 1973;
178:406-11.
5. Castaneda AR, Lamberti J, Sade RM, Williams RG, Nadas AS. Open-heart
surgery during the first three months of life. J Thorac Cardiovasc Surg. 1974;
68:719-31.
6. Pigula FA, Khalil PN, Mayer JE, del Nido PJ, Jonas RA. Repair of tetralogy of
Fallot in neonates and young infants. Circulation. 1999;100(Suppl):II157-61.
7. Mulder TJ, Pyles LA, Stolfi A, Pickoff AS, Moller JH. A multicenter analysis of
the choice of initial surgical procedure in tetralogy of Fallot. Pediatr Cardiol.
2002;23:580-6.
8. ParryAJ,McElhinneyDB,KungGC,ReddyVM,BrookMM,HanleyFL.Elective
primary repair of acyanotic tetralogy of Fallot in early infancy: overall outcome
and impact on the pulmonary valve. J Am Coll Cardiol. 2000;36:2279-83.
9. Reddy VM, Liddicoat JR, McElhinney DB, Brook MM, Stanger P, Hanley FL.
Routine primary repair of tetralogy of Fallot in neonates and infants less than
three months of age. Ann Thorac Surg. 1995;60:S592-6.
10. Fermanis GG, Ekangaki AK, Salmon AP, Keeton BR, Shore DF, Lamb RK, et al.
Twelve year experiencewith themodified Blalock-Taussig shunt in neonates.Eur
J Cardiothorac Surg. 1992;6:586-9.
11. Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The
modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot’s tetral-
ogy in the current era. J Thorac Cardiovasc Surg. 1997;114:25-30.
12. Sousa Uva M, Chardigny MC, Galetti L, Lacour Gayet F, Roussin R, Serraf A,
et al. Surgery for tetralogy of Fallot at less than six months of age. Is palliation
‘‘old-fashioned’’? Eur J Cardiothorac Surg. 1995;9:453-9; discussion 459-60.
13. Van Arsdell GS, Maharaj GS, Tom J, Rao VK, Coles JG, Freedom RM, et al.
What is the optimal age for repair of tetralogy of Fallot? Circulation. 2000;
102(Suppl 3):III123-9.
14. Al Habib HF, Jacobs JP, Mavroudis C, Tchervenkov CI, O’Brien SM,
Mohammadi S, et al. Contemporary patterns of management of tetralogy of Fal-
lot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg.
2010;90:813-9; discussion 819-20.
15. Owner Hospitals. Child Health Corporation of America. Available from: http://
www.chca.com./index_flash.html. Accessed December 3, 2012.
16. Centers for Disease Control and Prevention, National Center for Health Statistics.
International Classification of Diseases, Ninth Revision, Clinical Modification.
Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed December 7,
2012.
17. CTC Resources. Child Health Corporation of America. Available from: http://
www.chca.com./index_flash.html. Accessed: Dec 03, 2012.
18. Karl TR, Sano S, Pornviliwan S, Mee RB. Tetralogy of Fallot: favorable outcome
of neonatal transatrial, transpulmonary repair. Ann Thorac Surg. 1995;109:
332-44.
19. Vobecky SJ, Williams WG, Trusler GA, Coles JG, Rebeyka IM, Smallhorn J,
et al. Survival analysis of infants under 18 months presenting with tetralogy of
Fallot. Ann Thorac Surg. 1993;56:944-50.
20. Ooi A, Moorjani N, Baliulis G, Keeton BR, Salmon AP, Monro JL, et al. Medium
term outcome for infant repair in tetralogy of Fallot: indicators for timing of sur-
gery. Eur J Cardiothorac Surg. 2006;30:917-22.
21. Pasquali S, Peterson E, Jacobs J, He X, Li J, Jacobs M, et al. Differential case
ascertainment in clinical registry versus administrative data and impact on out-
comes assessment for pediatric cardiac operations. Ann Thorac Surg. 2013;95:
197-203.diovascular Surgery c Volume 147, Number 4 1305
